Carson Lisa Cabott
SEC insider (Form 3/4/5 filer). CIK 0002073513. Chief Financial Officer at Phio Pharmaceuticals Corp. (PHIO). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 28, 2026. Located in KING OF PRUSSIA, PA.
Companies Carson Lisa Cabott has filed insider reports for
- Phio Pharmaceuticals Corp. (PHIO): Officer, Chief Financial Officer
Carson Lisa Cabott
CIK: 0002073513
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PHIO
Phio Pharmaceuticals Corp.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 28, 2026PHIO
Phio Pharmaceuticals Corp.
AwardDirect108K shares- - Sep 11, 2026PHIO
Phio Pharmaceuticals Corp.
Tax PaymentDirect12.9K shares at avg. $1.03$13K - Feb 5, 2026PHIO
Phio Pharmaceuticals Corp.
AwardDirect47K shares- - Sep 11, 2025PHIO
Phio Pharmaceuticals Corp.
AwardDirect47K shares-
1-4 of 4 transactions